<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00006411</url>
  </required_header>
  <id_info>
    <org_study_id>NEI-80</org_study_id>
    <secondary_id>5U10EY012358</secondary_id>
    <secondary_id>3U10EY012358-11S1</secondary_id>
    <secondary_id>5U10EY012728</secondary_id>
    <nct_id>NCT00006411</nct_id>
  </id_info>
  <brief_title>Cornea Donor Study</brief_title>
  <acronym>CDS</acronym>
  <official_title>Cornea Donor Study: The Effect of Donor Age on Penetrating Keratoplasty for Endothelial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eye Bank Association of America</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tissue Banks International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vision Share, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Diego Eye Bank</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cornea Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Katena Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>ViroMed Laboratories, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Midwest Eye Banks</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Konan Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eye Bank for Sight Restoration</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SightLife</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sight Society of Northeastern New York (Lions Eye Bank of Albany)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lions Eye Bank of Oregon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Eye Institute (NEI)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Cornea Donor Study (CDS) was designed as a prospective cohort study with the following
      objectives:

      To determine whether the graft-failure rate over a 5-year follow-up period following corneal
      transplantation is the same when using corneal tissue from donors older than 65 years of age
      compared with tissue from younger donors.

      To assess the relationship between donor/recipient ABO blood type compatibility and graft
      failure due to rejection.

      To assess corneal endothelial cell density as an indicator of the health of the cornea and as
      a alternate outcome measure (in an optional Specular Microscopy Ancillary Study).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study enrolled 1101 subjects with a corneal disease considered to be at moderate risk for
      failure (principally Fuchs' dystrophy and pseudophakic corneal edema). A donor cornea meeting
      the following criteria was assigned to the subject by one of 43 participating eye banks:

        -  donor age 10 to 75 years

        -  endothelial cell count 2300 to 3300

        -  tissue quality very good to excellent

        -  death to preservation time &lt;12 hrs if body refrigerated or eyes on ice and &lt;8 hrs if not

        -  death to surgery time &lt;5 days

      The cornea surgeon (investigator) and patient were masked to donor age and characteristics of
      the donor cornea. Preoperative management, surgical technique, and postoperative care,
      including prescription of medications, were provided according to each investigator's
      customary routine. The follow-up visit schedule for the initial six months was left to each
      investigator's discretion and after this time the minimum follow-up visit schedule included a
      visit between six and 12 months and then one visit every 12 months through five years. The
      primary study outcome was graft survival at five years. The definition of graft failure,
      based on the definition used in Collaborative Corneal Transplantation Studies, was a regraft
      or, in the absence of regraft, a cloudy cornea in which there was loss of central graft
      clarity sufficient to compromise vision for a minimum of three consecutive months. Follow-up
      in the initial phase of the study continued for five years unless the patient had a regraft
      of the study eye.

      For the ABO compatibility study, the ABO blood type of both the donor and recipient were
      determined in order to compare the rate of graft failure for ABO-compatible cases with the
      rate for ABO-incompatible cases.

      For the Specular Microscopy Ancillary Study, endothelial cell counts were determined from
      specular images by a central reading center, and the relationship of the cell counts to donor
      age were assessed. In the initial phase of the study, specular images were obtained at 6
      months, and then annually through five years post-transplant.

      Five-year follow up was completed in November 2007. The 5-year cumulative probability of
      success was 86%: 86% in the &lt;66.0 year donor age group and 86% in the &gt;=66.0 year donor age
      group (difference = 0%, upper limit of one-sided 95% confidence interval = 4%). Adjusting for
      baseline endothelial cell density had no appreciable effect on these results. In a
      statistical model with donor age as a continuous variable, there was not a significant
      relationship between donor age and outcome (P=0.11). Three graft failures were due to primary
      donor failure, 8 to uncorrectable refractive error, 48 to graft rejection, 46 to endothelial
      decompensation, and 30 to other causes. At least one probable or definite graft rejection
      episode preceded graft failure in 23 of the 46 failures attributed to endothelial
      decompensation (4 definite and 19 probable) and in 18 of the 30 failures attributed to other
      causes (4 definite and 14 probable). The distribution of causes of failure between the donor
      age groups did not substantially differ.

      Although the 5-year results indicated no difference in the success rate of moderate-risk
      transplants according to donor age, results from the SMAS indicated that among the successful
      cases, there was a slight association between donor age and endothelial cell loss, with the
      cell loss after 5 years being slightly lower in corneas from younger donors (r adjusted for
      baseline endothelial cell density = -0.19, 95% confidence interval -0.29 to -0.08). Whether
      this slight association between cell loss and donor age is of clinical importance is not
      known. Of perhaps even greater importance, however, was the finding that irrespective of
      donor age, endothelial cell loss was substantial over the first five years after transplant
      even when the graft had been successful. Half of the successful cases experienced a cell loss
      of 70% or more, and at five years more than half had an endothelial cell density &lt;800
      cells/mm2.

      Patients in the CDS continued in annual follow up through 2012 in order to to determine the
      overall 10-year survival rate for moderate risk grafts and to determine whether the
      graft-failure rate is related to donor age. Additional objectives included determining the
      value of endothelial cell density in predicting graft failure and evaluating donor and
      recipient characteristics that may be predictive of late graft failure. All CDS subjects who
      were active at the 5-year exam were eligible for the extended follow-up phase.

      As part of the Specular Microscopy Ancillary Study, follow-up images were obtained during the
      extended follow-up phase at 7-8 years and again at 10-years. The same procedures used during
      the first 5 years were followed for the grading of the 7-8 year and 10-year images.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2000</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">December 31, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graft Failure</measure>
    <time_frame>Baseline to 10 Years of Follow Up</time_frame>
    <description># eyes with graft failure, defined as a regraft or a cloudy cornea that was sufficiently opaque as to compromise vision for a minimum of three consecutive months. Only one eye per participant was included in the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial Cell Density (ECD)</measure>
    <time_frame>10 year ECD</time_frame>
    <description>ECD (cells/mm2)was measured on a subset of the overall Cornea Donor Study cohort who participated in the Specular Microscopy Ancillary Study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1090</enrollment>
  <condition>Corneal Disease</condition>
  <condition>Fuch's Dystrophy</condition>
  <condition>Pseudophakic Corneal Edema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cornea assigned from donor age group &lt;66.0 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cornea assigned from donor age group &gt;= 66.0 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>corneas assigned by donor age group</intervention_name>
    <description>A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion

          1. Age range 40-80 years

          2. Corneal disease: Presence of a condition associated with endothelial dysfunction,
             including pseudophakic/aphakic corneal edema, Fuchs' dystrophy, posterior polymorphous
             dystrophy, interstitial keratitis (nonherpetic) or perforating corneal injury

          3. Willingness to be followed for 5 years and life expectancy at least 5 years (in
             investigator's judgement)

        Exclusion

          1. Patients are to be excluded when there is:

               -  a high risk of graft failure, including failed prior penetrating keratoplasty in
                  the eye to be transplanted, chemical burns or other significant cicatricial
                  conjunctivitis (ocular surface disease), herpes simplex/zoster, temporary
                  keratoprosthesis, iridocorneal endothelial syndrome or any corneal condition in
                  which there are two or more quadrants of stromal neovascularization

                    -  A quadrant is considered vascularized if there is at least one patent
                       stromal vessel &gt;2.0 mm in length crossing the limbus within a quadrant. Two
                       quadrants are considered vascularized if there are at least two stromal
                       vessels 90ยบ or more apart. Enrollment will be restricted to no more than 20%
                       of the total cohort having stromal neovascularization.

                    -  Patients should be excluded if there are PAS or other abnormalities that, in
                       the view of the investigator, place the patient at high risk for graft
                       failure.

               -  a very high probability of success including keratoconus, stromal dystrophies,
                  stromal scars without edema or post-refractive surgery with healthy endothelium

          2. Uncontrolled glaucoma or prior filtering surgery with placement of a shunt in the eye
             to be grafted (Note: eyes requiring a filtering procedure combined with the PK are
             considered to have uncontrolled glaucoma and are ineligible. Eyes which have undergone
             filtering surgery (without a shunt) in which glaucoma is currently considered under
             control are eligible)

          3. Uncontrolled uveitis in the eye to be grafted

          4. Fellow eye visual acuity &lt;20/200

          5. Fellow eye already included in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward J Holland, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Cincinnati and Cincinnati Eye Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark J Mannis, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roy W Beck, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jaeb Center for Health Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jonathan H Lass, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>(PI of Specular Microscopy Ancillary Study), Case Western Reserve University and University Hospitals Case Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jaeb Center for Health Research, Inc.</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33647</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Beck RW, Gal RL, Mannis MJ, Holland EJ, Cavanagh HD, Foulks GN, Heck EL, Lindquist T, Macsai MS, Smith RE, Stark WJ, Stulting RD, Sugar J. Is donor age an important determinant of graft survival? Cornea. 1999 Sep;18(5):503-10. Review.</citation>
    <PMID>10487423</PMID>
  </reference>
  <reference>
    <citation>Powe A, Gal RL, Beck RW, Mannis MJ, Holland EJ on behalf of the Cornea Donor Study Investigator Group. The Cornea Donor Study. Vision Pan-America 2009; 8:134-137.</citation>
  </reference>
  <results_reference>
    <citation>Sugar A, Gal RL, Beck rW, Ruedy KJ, Blanton CL, Feder RS, Hardten DR, Holland EJ, Lass JH, Mannis MJ, O'Keefe MB; Cornea Donor Study Group. Baseline donor characteristics in the Cornea Donor Study. Cornea. 2005 May;24(4):389-96.</citation>
    <PMID>15829793</PMID>
  </results_reference>
  <results_reference>
    <citation>Lass JH, Gal RL, Ruedy KJ, Benetz BA, Beck RW, Baratz KH, Holland EJ, Kalajian A, Kollman C, Manning FJ, Mannis MJ, McCoy K, Montoya M, Stulting D, Xing D; Cornea Donor Study Group. An evaluation of image quality and accuracy of eye bank measurement of donor cornea endothelial cell density in the Specular Microscopy Ancillary Study. Ophthalmology. 2005 Mar;112(3):431-40. Erratum in: Ophthalmology. 2005 Aug;112(8):1394.</citation>
    <PMID>15745770</PMID>
  </results_reference>
  <results_reference>
    <citation>Mannis MJ, Holland EJ, Beck RW, Belin MW, Goldberg MA, Gal RL, Kalajian AD, Kenyon KR, Kollman C, Ruedy KJ, Smith P, Sugar J, Stark WJ; Cornea Donor Study Group. Clinical profile and early surgical complications in the Cornea Donor Study. Cornea. 2006 Feb;25(2):164-70.</citation>
    <PMID>16371775</PMID>
  </results_reference>
  <results_reference>
    <citation>Benetz BA, Gal RL, Ruedy KJ, Rice C, Beck RW, Kalajian AD, Lass JH; Cornea Donor Study Group. Specular microscopy ancillary study methods for donor endothelial cell density determination of Cornea Donor Study images. Curr Eye Res. 2006 Apr;31(4):319-27.</citation>
    <PMID>16603465</PMID>
  </results_reference>
  <results_reference>
    <citation>Cornea Donor Study Investigator Group, gal RL, Dontchev M, Beck RW, Mannis MJ, Holland EJ, Kollman C, Dunn SP, Heck EL, Lass JH, Montoya MM, Schultze RL, Stulting RD, Sugar A, Sugar J, Tennant B, Verdier DD. The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology. 2008 Apr;115(4):620-626.e6. doi: 10.1016/j.ophtha.2008.01.003.</citation>
    <PMID>18387407</PMID>
  </results_reference>
  <results_reference>
    <citation>Cornea Donor Study Investigator Group, Lass JH, Gal RL, Dontchev M, Beck RW, Kollman C, Dunn SP, Heck E, Holland EJ, Mannis MJ, Montoya MM, Schultze RL, Stulting RD, Sugar A, Sugar J, Tennant B, Verdier DD. Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology. 2008 Apr;115(4):627-632.e8. doi: 10.1016/j.ophtha.2008.01.004.</citation>
    <PMID>18387408</PMID>
  </results_reference>
  <results_reference>
    <citation>Sugar A, Tanner JP, Dontchev M, Tennant B, Schultze RL, Dunn SP, Lindquist TD, Gal RL, Beck RW, Kollman C, Mannis MJ, Holland EJ; Cornea Donor Study Investigator Group. Recipient risk factors for graft failure in the cornea donor study. Ophthalmology. 2009 Jun;116(6):1023-8. doi: 10.1016/j.ophtha.2008.12.050. Epub 2009 Apr 23.</citation>
    <PMID>19395036</PMID>
  </results_reference>
  <results_reference>
    <citation>Sugar J, Montoya M, Dontchev M, Tanner JP, Beck R, Gal R, Gallagher S, Gaster R, Heck E, Holland EJ, Kollman C, Malling J, Mannis MJ, Woody J; Group Cornea Donor Study Investigator Group. Donor risk factors for graft failure in the cornea donor study. Cornea. 2009 Oct;28(9):981-5. doi: 10.1097/ICO.0b013e3181a0a3e6.</citation>
    <PMID>19724216</PMID>
  </results_reference>
  <results_reference>
    <citation>Dunn SP, Stark WJ, Stulting RD, Lass JH, Sugar A, Pavilack MA, Smith PW, Tanner JP, Dontchev M, Gal RL, Beck RW, Kollman C, Mannis MJ, Holland EJ; Cornea Donor Study Investigator Group. The effect of ABO blood incompatibility on corneal transplant failure in conditions with low-risk of graft rejection. Am J Ophthalmol. 2009 Mar;147(3):432-438.e3. doi: 10.1016/j.ajo.2008.09.021. Epub 2008 Dec 4.</citation>
    <PMID>19056078</PMID>
  </results_reference>
  <results_reference>
    <citation>Lass JH, Sugar A, Benetz BA, Beck RW, Dontchev M, Gal RL, Kollman C, Gross R, Heck E, Holland EJ, Mannis MJ, Raber I, Stark W, Stulting RD; Cornea Donor Study Investigator Group. Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty. Arch Ophthalmol. 2010 Jan;128(1):63-9. doi: 10.1001/archophthalmol.2010.128.63.</citation>
    <PMID>20065219</PMID>
  </results_reference>
  <results_reference>
    <citation>Lass JH, Beck RW, Benetz BA, Dontchev M, Gal RL, Holland EJ, Kollman C, Mannis MJ, Price F Jr, Raber I, Stark W, Stulting RD, Sugar A; Cornea Donor Study Investigator Group. Baseline factors related to endothelial cell loss following penetrating keratoplasty. Arch Ophthalmol. 2011 Sep;129(9):1149-54. doi: 10.1001/archophthalmol.2011.102. Epub 2011 May 9. Erratum in: Arch Ophthalmol. 2011 Dec;129(12):1640.</citation>
    <PMID>21555600</PMID>
  </results_reference>
  <results_reference>
    <citation>Stulting RD, Sugar A, Beck R, Belin M, Dontchev M, Feder RS, Gal RL, Holland EJ, Kollman C, Mannis MJ, Price F Jr, Stark W, Verdier DD; Cornea Donor Study Investigator Group. Effect of donor and recipient factors on corneal graft rejection. Cornea. 2012 Oct;31(10):1141-7.</citation>
    <PMID>22488114</PMID>
  </results_reference>
  <results_reference>
    <citation>Sugar A, Montoya MM, Beck R, Cowden JW, Dontchev M, Gal RL, Kollman C, Malling J, Mannis MJ, Tennant B; Cornea Donor Study Investigator Group. Impact of the cornea donor study on acceptance of corneas from older donors. Cornea. 2012 Dec;31(12):1441-5. doi: 10.1097/ICO.0b013e31823f7550.</citation>
    <PMID>22262218</PMID>
  </results_reference>
  <results_reference>
    <citation>Verdier DD, Sugar A, Baratz K, Beck R, Dontchev M, Dunn S, Gal RL, Holland EJ, Kollman C, Lass JH, Mannis MJ, Penta J; Cornea Donor Study Investigator Group. Corneal thickness as a predictor of corneal transplant outcome. Cornea. 2013 Jun;32(6):729-36. doi: 10.1097/ICO.0b013e31827b14c7.</citation>
    <PMID>23343949</PMID>
  </results_reference>
  <results_reference>
    <citation>Benetz BA, Lass JH, Gal RL, Sugar A, Menegay H, Dontchev M, Kollman C, Beck RW, Mannis MJ, Holland EJ, Gorovoy M, Hannush SB, Bokosky JE, Caudill JW; Cornea Donor Study Investigator Group. Endothelial morphometric measures to predict endothelial graft failure after penetrating keratoplasty. JAMA Ophthalmol. 2013 May;131(5):601-608. doi: 10.1001/jamaophthalmol.2013.1693.</citation>
    <PMID>23493999</PMID>
  </results_reference>
  <results_reference>
    <citation>Writing Committee for the Cornea Donor Study Research Group, Mannis MJ, Holland EJ, Gal RL, Dontchev M, Kollman C, Raghinaru D, Dunn SP, Schultze RL, Verdier DD, Lass JH, Raber IM, Sugar J, Gorovoy MS, Sugar A, Stulting RD, Montoya MM, Penta JG, Benetz BA, Beck RW. The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study. Ophthalmology. 2013 Dec;120(12):2419-2427. doi: 10.1016/j.ophtha.2013.08.026.</citation>
    <PMID>24246825</PMID>
  </results_reference>
  <results_reference>
    <citation>Writing Committee for the Cornea Donor Study Research Group, Lass JH, Benetz BA, Gal RL, Kollman C, Raghinaru D, Dontchev M, Mannis MJ, Holland EJ, Chow C, McCoy K, Price FW Jr, Sugar A, Verdier DD, Beck RW. Donor age and factors related to endothelial cell loss 10 years after penetrating keratoplasty: Specular Microscopy Ancillary Study. Ophthalmology. 2013 Dec;120(12):2428-2435. doi: 10.1016/j.ophtha.2013.08.044.</citation>
    <PMID>24246826</PMID>
  </results_reference>
  <results_reference>
    <citation>Dunn SP, Gal RL, Kollman C, Raghinaru D, Dontchev M, Blanton CL, Holland EJ, Lass JH, Kenyon KR, Mannis MJ, Mian SI, Rapuano CJ, Stark WJ, Beck RW; Writing Committee for the Cornea Donor Study Research Group. Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study. Cornea. 2014 Oct;33(10):1003-9. doi: 10.1097/ICO.0000000000000212.</citation>
    <PMID>25119961</PMID>
  </results_reference>
  <results_reference>
    <citation>Riddlesworth TD, Kollman C, Lass JH, Patel SV, Stulting RD, Benetz BA, Gal RL, Beck RW. A mathematical model to predict endothelial cell density following penetrating keratoplasty with selective dropout from graft failure. Invest Ophthalmol Vis Sci. 2014 Nov 25;55(12):8409-15. doi: 10.1167/iovs.14-15683.</citation>
    <PMID>25425307</PMID>
  </results_reference>
  <results_reference>
    <citation>Writing Committee for the Cornea Donor Study Research Group, Sugar A, Gal RL, Kollman C, Raghinaru D, Dontchev M, Croasdale CR, Feder RS, Holland EJ, Lass JH, Macy JI, Mannis MJ, Smith PW, Soukiasian SH, Beck RW. Factors associated with corneal graft survival in the cornea donor study. JAMA Ophthalmol. 2015 Mar;133(3):246-54. doi: 10.1001/jamaophthalmol.2014.3923.</citation>
    <PMID>25322173</PMID>
  </results_reference>
  <results_reference>
    <citation>Lass JH, Riddlesworth TD, Gal RL, Kollman C, Benetz BA, Price FW Jr, Sugar A, Terry MA, Soper M, Beck RW; Cornea Donor Study Research Group. The effect of donor diabetes history on graft failure and endothelial cell density 10 years after penetrating keratoplasty. Ophthalmology. 2015 Mar;122(3):448-56. doi: 10.1016/j.ophtha.2014.09.012. Epub 2014 Nov 15.</citation>
    <PMID>25439611</PMID>
  </results_reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>October 13, 2000</study_first_submitted>
  <study_first_submitted_qc>October 13, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2000</study_first_posted>
  <results_first_submitted>September 26, 2014</results_first_submitted>
  <results_first_submitted_qc>February 24, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 25, 2020</results_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cornea transplant</keyword>
  <keyword>corneal endothelial cell density</keyword>
  <keyword>moderate risk corneal diseases</keyword>
  <keyword>corneal transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
    <mesh_term>Corneal Edema</mesh_term>
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Public dataset access: http://cds.jaeb.org/Studies.aspx?RecID=185</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cornea Assigned From Donor Age Group &lt;66.0 Years</title>
          <description>cornea assigned from donor age group &lt;66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
        </group>
        <group group_id="P2">
          <title>Cornea Assigned From Donor Age Group &gt;= 66.0 Years</title>
          <description>cornea assigned from donor age group &gt;= 66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="707"/>
                <participants group_id="P2" count="383"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="707"/>
                <participants group_id="P2" count="383"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cornea Assigned From Donor Age Group &lt;66.0 Years</title>
          <description>cornea assigned from donor age group &lt;66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
        </group>
        <group group_id="B2">
          <title>Cornea Assigned From Donor Age Group &gt;= 66.0 Years</title>
          <description>cornea assigned from donor age group &gt;= 66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="707"/>
            <count group_id="B2" value="383"/>
            <count group_id="B3" value="1090"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69" spread="9"/>
                    <measurement group_id="B2" value="71" spread="8"/>
                    <measurement group_id="B3" value="70" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="445"/>
                    <measurement group_id="B2" value="252"/>
                    <measurement group_id="B3" value="697"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="262"/>
                    <measurement group_id="B2" value="131"/>
                    <measurement group_id="B3" value="393"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Graft Failure</title>
        <description># eyes with graft failure, defined as a regraft or a cloudy cornea that was sufficiently opaque as to compromise vision for a minimum of three consecutive months. Only one eye per participant was included in the study.</description>
        <time_frame>Baseline to 10 Years of Follow Up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cornea Assigned From Donor Age Group &lt;66.0 Years</title>
            <description>cornea assigned from donor age group &lt;66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
          </group>
          <group group_id="O2">
            <title>Cornea Assigned From Donor Age Group &gt;= 66.0 Years</title>
            <description>cornea assigned from donor age group &gt;= 66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
          </group>
        </group_list>
        <measure>
          <title>Graft Failure</title>
          <description># eyes with graft failure, defined as a regraft or a cloudy cornea that was sufficiently opaque as to compromise vision for a minimum of three consecutive months. Only one eye per participant was included in the study.</description>
          <units>participants</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="707"/>
                <count group_id="O2" value="383"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="707"/>
                <count group_id="O2" value="383"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142"/>
                    <measurement group_id="O2" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Endothelial Cell Density (ECD)</title>
        <description>ECD (cells/mm2)was measured on a subset of the overall Cornea Donor Study cohort who participated in the Specular Microscopy Ancillary Study</description>
        <time_frame>10 year ECD</time_frame>
        <population>Of 1,090 eligible participants enrolled in the CDS, the SMAS included 609. A gradable endothelial image at 10 years was available for 176 participants. Among the other 433 participants, 105 had a graft failure, 100 died, 103 completed less than 10 years of CDS follow up, and 125 did not have a 10-year image for other reasons.</population>
        <group_list>
          <group group_id="O1">
            <title>Cornea Assigned From Donor Age Group &lt;66.0 Years</title>
            <description>cornea assigned from donor age group &lt;66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
          </group>
          <group group_id="O2">
            <title>Cornea Assigned From Donor Age Group &gt;= 66.0 Years</title>
            <description>cornea assigned from donor age group &gt;= 66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
          </group>
        </group_list>
        <measure>
          <title>Endothelial Cell Density (ECD)</title>
          <description>ECD (cells/mm2)was measured on a subset of the overall Cornea Donor Study cohort who participated in the Specular Microscopy Ancillary Study</description>
          <population>Of 1,090 eligible participants enrolled in the CDS, the SMAS included 609. A gradable endothelial image at 10 years was available for 176 participants. Among the other 433 participants, 105 had a graft failure, 100 died, 103 completed less than 10 years of CDS follow up, and 125 did not have a 10-year image for other reasons.</population>
          <units>ECD (cells/mm2)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="125"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="628" lower_limit="522" upper_limit="850"/>
                    <measurement group_id="O2" value="550" lower_limit="483" upper_limit="694"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Cornea Assigned From Donor Age Group &lt;66.0 Years</title>
          <description>cornea assigned from donor age group &lt;66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
        </group>
        <group group_id="E2">
          <title>Cornea Assigned From Donor Age Group &gt;= 66.0 Years</title>
          <description>cornea assigned from donor age group &gt;= 66.0 years
corneas assigned by donor age group: A web-based computer program was used to select and assign a cornea by donor age group from those available at the eye bank that met the study eligibility criteria. The program randomly selected a cornea based on a two-level minimization procedure which attempted first to balance for each surgeon the number of corneas from donors &gt;=66 and &lt;66 years old and then, when possible, to balance among age subgroups of 10-35, 36-50, 51-65, 66-70, and 71-75 years. The assignment was made without regard to recipient age or any other subject characteristics.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="707"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="383"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="707"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="383"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Roy W. Beck, MD, PhD</name_or_title>
      <organization>JCHR</organization>
      <phone>813-975-8690</phone>
      <email>cds@jaeb.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

